262 related articles for article (PubMed ID: 20492423)
1. Failure of PDE5 inhibitor use: a case of nonresponder? (CME).
Chung E
J Sex Med; 2010 Apr; 7(4 Pt 1):1321-3. PubMed ID: 20492423
[No Abstract] [Full Text] [Related]
2. Erectile dysfunction.
Katz A; Katz A
CMAJ; 2010 Mar; 182(4):381-2. PubMed ID: 20142374
[No Abstract] [Full Text] [Related]
3. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.
Jannini EA; Isidori AM; Gravina GL; Aversa A; Balercia G; Bocchio M; Boscaro M; Carani C; Corona G; Fabbri A; Foresta C; Forti G; Francavilla S; Granata AR; Maggi M; Mansani R; Palego P; Spera G; Vetri M; Lenzi A;
J Sex Med; 2009 Sep; 6(9):2547-60. PubMed ID: 19570039
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction: the proper drug for the proper patient.
Corona G; Mondaini N; Ungar A; Razzoli E; Rossi A; Fusco F
J Sex Med; 2011 Dec; 8(12):3418-32. PubMed ID: 21995676
[TBL] [Abstract][Full Text] [Related]
5. [PDE5 inhibitors in treatment of benign prostatic syndrome].
Sandner P; Tinel H; Stelte-Ludwig B; Huetter J; Neuser D; Bischoff E; Ulbrich E
Urologe A; 2007 Sep; 46(9):1189-92. PubMed ID: 17609921
[No Abstract] [Full Text] [Related]
6. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
Lombardi G; Nelli F; Celso M; Mencarini M; Del Popolo G
J Sex Med; 2012 Apr; 9(4):970-85. PubMed ID: 22304626
[TBL] [Abstract][Full Text] [Related]
7. 2009 update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME).
Shindel AW
J Sex Med; 2009 Jul; 6(7):1794-808; quiz 1793, 1809-10. PubMed ID: 19575771
[TBL] [Abstract][Full Text] [Related]
8. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
Mulhall JP; McLaughlin TP; Harnett JP; Scott B; Burhani S; Russell D
J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809
[TBL] [Abstract][Full Text] [Related]
9. 2009 update on phosphodiesterase type 5 inhibitor therapy part 2: updates on optimal utilization for sexual concerns and rare toxicities in this class.
Shindel AW
J Sex Med; 2009 Sep; 6(9):2352-64; quiz 2365-6. PubMed ID: 19735356
[TBL] [Abstract][Full Text] [Related]
10. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
[TBL] [Abstract][Full Text] [Related]
11. Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report.
Agrawal A; Tutuian R; Hila A; Castell DO
Dig Dis Sci; 2005 Nov; 50(11):2059-62. PubMed ID: 16240215
[No Abstract] [Full Text] [Related]
12. There have been inadequate warnings that erectile dysfunction drugs can cause blindness.
Wolfe SM
MedGenMed; 2005 Dec; 7(4):61. PubMed ID: 16614683
[No Abstract] [Full Text] [Related]
13. Is vardenafil "noninferior" or superior to sildenafil in the management of erectile dysfunction? Revisiting the biochemical, physiological, and clinical evidence.
Traish A; Kim N
J Sex Med; 2008 Jul; 5(7):1762-8; discussion 1768-9. PubMed ID: 18221281
[No Abstract] [Full Text] [Related]
14. New phosphodiesterase inhibitors in the treatment of erectile dysfunction.
Anderson PC; Gommersall L; Hayne D; Arya M; Patel HR
Expert Opin Pharmacother; 2004 Nov; 5(11):2241-9. PubMed ID: 15500370
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implications.
Agarwal P; Sander GE; Giles TD
Am J Geriatr Cardiol; 2004; 13(6):332-5. PubMed ID: 15538074
[No Abstract] [Full Text] [Related]
16. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
Hatzimouratidis K; Hatzichristou DG
Drugs; 2005; 65(12):1621-50. PubMed ID: 16060698
[TBL] [Abstract][Full Text] [Related]
17. [Birthday of a "potency pill". Helmut Newton celebrates posthumously likewise].
Keil TU
MMW Fortschr Med; 2004 Jul; 146(29-30):61. PubMed ID: 15540567
[No Abstract] [Full Text] [Related]
18. Patient education series. Erectile dysfunction.
Lewis JH; Rosen R; Goldstein I
Nursing; 2005 Feb; 35(2):64. PubMed ID: 15706284
[No Abstract] [Full Text] [Related]
19. How new drugs help treat erectile dysfunction.
Weeks B; Ficorelli CT
Nursing; 2006 Jan; 36(1):18-9. PubMed ID: 16394991
[No Abstract] [Full Text] [Related]
20. Erectile dysfunction and the drugs to treat it. In many cases, medications are all a man needs to stay sexually active.
Harv Health Lett; 2014 May; 39(7):7. PubMed ID: 25073193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
